stocksGoogle News
Baja Auto Q2 FY27 Results | Cipla Q2 FY27 Results | Top Buzzing Stocks Today - Equitymaster
Baja Auto Q2 FY27 Results | Cipla Q2 FY27 Results | Top Buzzing Stocks Today Equitymaster
GN1 hour ago
Read More//
Sigachi Laboratories Limited · Health Care · Sigachi Laboratories Unlisted / Pre-IPO Share Price
As of 29 Oct 2026, the Sigachi Laboratories Limited unlisted share price is ₹52 per share. Implied valuation: ₹35.12 Cr. Sigachi Laboratories Limited is an unlisted / pre-IPO company — not listed on NSE or BSE. Minimum investment: ₹50,000. ISIN: INE368H01018.
▼ ₹3 (−5.45%) over all time
Key figures for Sigachi Laboratories Limited
Sigachi Laboratories Limited is an Indian pharmaceutical company referenced for manufacturing active ingredients and intermediates, complementing the broader Sigachi group known for excipients. Public materials cite capabilities in compliant production, quality control and customer documentation to support formulations and regulated-market needs. The company supplies domestic and select export customers, focusing on reliability, technical service and adherence to applicable standards.
| Particulars | FY22 | FY23 | FY24 | FY25 | FY26 LATEST |
|---|---|---|---|---|---|
| Revenue | 260 | 195 | 374 | 312 | 326▲4% |
| EBITDA | 211 | 142 | 242 | 109 | 132▲21% |
| OPM (%) | 81.15% | 72.82% | 64.71% | 34.94% | 40.8%▲17% |
| PBT | 238 | 173 | 281 | 152 | 181▲19% |
| PAT | 200 | 131 | 197 | 119 | 134▲13% |
| EPS (₹) | ₹2.74 | ₹1.79 | ₹2.69 | ₹1.63 | ₹1.83▲12% |
Figures in ₹ Crore unless marked ₹ (per share) or %. Source: company filings via unlistedzone.
Sigachi Laboratories shares are unlisted, so they are bought off-market through a SEBI-registered intermediary rather than on the NSE or BSE. With Safal Capital the process is simple:
No. Sigachi Laboratories is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE and there is no live “Sigachi Laboratoriesshare price NSE”. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Sigachi Laboratories has not announced a confirmed IPO date. Investors buy unlisted shares ahead of a potential listing for pre-IPO upside, but a listing is never guaranteed and timelines can change. The ISIN for Sigachi Laboratories is INE368H01018. Contact our desk for the latest status and a live quote before you invest.
Sigachi Laboratories Limited is an unlisted company operating in the Health Care sector (Pharmaceuticals / Lab Services). Sigachi Laboratories Limited is an Indian pharmaceutical company referenced for manufacturing active ingredients and intermediates, complementing the broader Sigachi group known for excipients. Public materials cite capabilities in compliant production, quality control and customer documentation to …
The current unlisted market price is ₹51.48 per share with a market capitalisation of approximately ₹35 crore. The company is currently unlisted and investors should factor in illiquidity risk and longer holding horizons. Investors are advised to review the full financial data and consult an advisor before investing.
Leave your name and mobile, our unlisted shares desk will call you back with live pricing and availability.
Latest source-linked updates that may be relevant to this company.
Baja Auto Q2 FY27 Results | Cipla Q2 FY27 Results | Top Buzzing Stocks Today Equitymaster
Ambani’s Jio to make Mumbai trading debut after record $3.2 billion India IPO The Manila Times
Jio Shares Debut With 21% Premium Following Record $3.2 Billion IPO The CSR Journal
As of 29 Oct 2026, the Sigachi Laboratories unlisted (pre-IPO) share price is ₹52 per share on Safal Capital. Unlisted share prices move with demand, supply and deal size, so contact our desk for a live, deal-specific quote before you transact.
At the unlisted share price of ₹52, Sigachi Laboratories's implied market valuation is about ₹35.12 Cr (share price × total shares outstanding). This is an indicative, market-implied figure that moves with the unlisted price — not an official company valuation.
You buy Sigachi Laboratories unlisted shares off-market through a SEBI-registered intermediary. With Safal Capital: (1) share your requirement and quantity, (2) we confirm the live price and availability, (3) you complete KYC, (4) transfer funds, and (5) the shares are credited to your demat account, usually within T+1 to T+2 working days.
No. Sigachi Laboratories is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Sigachi Laboratories has not announced a confirmed IPO date. Unlisted shares are often bought before a potential listing in the hope of pre-IPO gains, but a listing is never guaranteed and timelines can change. Speak to our advisors for the latest status on Sigachi Laboratories.
The ISIN for Sigachi Laboratories unlisted shares is INE368H01018. You will need this ISIN when the shares are credited to your demat account.
Sigachi Laboratories unlisted shares have a face value of ₹10 and a typical minimum lot of 1000 shares. Minimum quantities can vary with availability and deal size — our desk will confirm the current lot before you invest.
Unlisted share prices are not set by an exchange. The Sigachi Laboratories price reflects recent off-market deals, buyer/seller demand, the company's financials and expectations around a future IPO. Because it is over-the-counter, always confirm a live quote before transacting.
Unlisted shares like Sigachi Laboratories can offer pre-IPO upside but carry higher risk and lower liquidity than listed stocks, and there is no guaranteed exit. Invest only after reviewing the company's fundamentals and your risk profile — Safal Capital's SEBI-registered advisors can help you assess Sigachi Laboratories.
Unlisted shares like Sigachi Laboratories are high-growth but illiquid. Balance them with these — all with the same SEBI-registered team.